Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Tofacitinib oral sustained release dosage forms

Tofacitinib oral sustained release dosage forms

US Patent 9937181 · Granted Apr 10, 2018

Estimated economic value: $630,119,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Tofacitinib oral sustained release dosage forms2022
Tofacitinib oral sustained release dosage forms2022
Tofacitinib oral sustained release dosage forms2022
Tofacitinib oral sustained release dosage forms2022
Tofacitinib oral sustained release dosage forms2022
Tofacitinib oral sustained release dosage forms2020
Tofacitinib oral sustained release dosage forms2020
Tofacitinib oral sustained release dosage forms2020
Tofacitinib oral sustained release dosage forms2020
Tofacitinib oral sustained release dosage forms2020
Solid pharmaceutical dispersions with enhanced bioavailability2013
Solid pharmaceutical dispersions with enhanced bioavailability2013